Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2017
At a glance
- Drugs Sildenafil (Primary)
- Indications Glucose intolerance
- Focus Pharmacodynamics
- 28 Oct 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Nov 2016.
- 18 Nov 2015 Results published in the Journal of Clinical Endocrinology and Metabolism
- 06 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.